Trials

  • CERC Trial

    EASY TAVI

    -

    The purpose of this study is to determine whether a left ventricular rapid pacing using the valve delivery guide-wire in transcatheter aortic valve implantation (TAVI) reduces the overall procedure duration in comparison with the conventional method. Use of temporary pacing via a right ventricular...

  • CERC Trial

    EBC DCB

    -

    The European Bifurcation Club randomized trial of stepwise provisional stenting versus Drug Coated Balloon Therapy for non-left main true coronary bifurcations Legal Representative of Sponsor in European Union: CERC Investigator Initiated Trial The EBC DCB study is an investigator initiated, multi...

  • CERC Trial

    EBC MAIN

    -

    Treatment of bifurcation coronary lesions remains a difficult area, in which best practice is yet to be established. This is particularly true with respect to unprotected left main stem stenting. Whereas for non-left main bifurcation lesions there is a consensus that a single stent strategy is to be...

  • CERC Trial

    EESIS-FR

    -

    This is a multicentre post marketing study in France evaluating the safety and efficacy of the eCLIPs™ Family of Products for the treatment of bifurcation intracranial aneurysms at the carotid and basilar terminus. The eCLIPs device is the first neuro device that has gained Innovation funding (in...

  • CERC Trial

    ELECTRODUCER

    -

    The objective of this trial is to assess the peri procedural safety of ELECTRODUCER SLEEVE device used for temporary cardiac pacing during percutaneous cardiovascular interventions, by radial and femoral routes of access. This is a pilot, prospective, multi-center, non-comparative study in 60...

  • CERC Trial

    EucaLimus Post-Market Registry

    -

    Single-arm, Prospective, Open label, All Comers, Multicenter Registry. The objective is to assess safety and performance of EucaLimus, a sirolimus eluting PTCA stent system, in a prospective study as part of the manufacturer‘s post-market surveillance program

  • CERC Trial

    EURO SHOCK

    -

    Cardiogenic shock (CGS) affects up to 10% of patients suffering acute coronary syndrome. It has a 30 day mortality of 45-50%. No pharmacological nor intervention/device trials have had any impact on this mortality in the last 20 years. The EURO SHOCK Trial (supported by the European Union Horizons...

  • CERC Trial

    EuroCTO

    -

    CTOs are common among patients with angina, and are detected in around 20% of patients undergoing coronary angiography. Treatment of CTO has been found to constitute only 7% of PCI practice on average. One of the reasons for the under-presentation of CTOs in PCI target lesions is the lack of...

  • CERC Trial

    EuroNetrod HTN OFF-Med

    -

    EuroNetrod HTN OFF-Med Study is a multi-center blinded, 3-arm randomized (2:1:1) controlled investigation that aims to evaluate the efficacy and safety of the Netrod™ RDN system in patients with uncontrolled primary hypertension in the absence of antihypertensive medication, comparing the outcomes...

  • CERC Trial

    EVERGREEN

    -

    Evaluation of the Valiant Captivia Physician fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies (EVERGREEN) EVERGREEN study is a prospective, multi-center, multinational, single arm study. The objective is to evaluate the safety and effectiveness of Valiant...